Thrombin, a mediator of neurotoxicity and memory impairment

Neurobiology of Aging

Volumn 25, Issue 6, 2004, Pages 783-793

  Mhatre, Molina ^a   Nguyen, Albert ^a   Kashani, Shabnam ^a   Pham, Tracy ^a   Adesina, Adekunle ^a   Grammas, Paula ^a,b  

^a UNIVERSITY OF OKLAHOMA COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF OKLAHOMA   (United States)

Author keywords

Cognition; Glial fibrillary acidic protein; Memory deficits; Neurofilament; Neurotoxicity; Spatial memory; Thrombin

Indexed keywords

APOLIPOPROTEIN E; HIRUDIN; THROMBIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASTROCYTOSIS; BRAIN VENTRICLE; COGNITION; COGNITIVE DEFECT; CONTROLLED STUDY; IMMUNOREACTIVITY; IN VIVO CULTURE; INFUSION; MALE; MAZE TEST; MEMORY DISORDER; NEUROFILAMENT; NEUROPATHOLOGY; NEUROTOXICITY; NICK END LABELING; NONHUMAN; PHOSPHORYLATION; PRIORITY JOURNAL; RAT; TASK PERFORMANCE;

ANIMALS; APOLIPOPROTEINS E; BEHAVIOR, ANIMAL; BLOTTING, WESTERN; BRAIN; CELL COUNT; CELL DEATH; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG INTERACTIONS; FIBRINOLYTIC AGENTS; GLIAL FIBRILLARY ACIDIC PROTEIN; HEMOSTATICS; HIRUDIN THERAPY; HUMANS; IMMUNOHISTOCHEMISTRY; IN SITU NICK-END LABELING; MALE; MAZE LEARNING; MEMORY DISORDERS; MOTOR ACTIVITY; NEUROFILAMENT PROTEINS; RATS; RATS, SPRAGUE-DAWLEY; REACTION TIME; THROMBIN;

EID: 2542561236     PISSN: 01974580     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neurobiolaging.2003.07.007     Document Type: Article

References (55)

1. Akiyama H., Ikeda K., Kondo H., McGeer P.L. Thombin accumulation in patients with Alzheimer's disease. Neurosci. Lett. 146:1992;152-154
2. Armao D., Kornfeld M., Estrada E.Y., Grossetete M., Rosenberg G.A. Neutral proteases and disruption of the blood-brain barrier in rat. Brain Res. 767:1997;259-264
3. Bimonte-Nelson H.A., Hunter C.L., Nelson M.E., Granholm A.C. Frontal cortex BDNF levels correlate with working memory in an animal model of Down syndrome. Behav. Brain Res. 139:2003;47-57
4. Breteler M.M., van Amerongen N.M., van Swieten J.C., Claus J.J., Grobbee D.E., van Gijn J., et al. Cognitive correlates of ventricular enlargement and cerebral white matter lesions on magnetic resonance imaging. The Rotterdam Study. Stroke. 25:1994;1109-1115
5. Castillo J., Dávalos A., Álvarez-Sabín J., Pumar J.M., Leira R., Silva Y., et al. Molecular signatures of brain injury after intracerebral hemorrhage. Neurology. 58:2002;624-629
6. Cavanaugh K.P., Gurwitz D., Cunningham D.D., Bradshaw R.A. Reciprocal modulation of astrocyte stellation by thrombin and protease nexin-1. J. Neurochem. 54:1990;1735-1743
7. Chong Y.H., Jung J.M., Choi W., Park C.W., Choi K.S., Suh Y.H. Bacterial expression, purification of full length and carboxyl terminal fragment of Alzheimer amyloid precursor protein and their proteolytic processing by thrombin. Life Sci. 4:1994;1259-1268
8. Ciallella J.R., Figueiredo H., Smith-Swintosky V., McGillis J.P. Thrombin induces surface and intracellular secretion of amyloid precurser protein from human endothelial cells. Thromb. Haemost. 81:1999;630-637
9. Colon G.P., Lee K.R., Keep R.F., Chenevert T.L., Betz A.L., Hoff J.T. Thrombin-soaked gelatin sponge and brain edema in rats. J. Neurosurg. 85:1996;335-339
10. Conti A.C., Raghupathi R., Trojanowski J.Q., McIntosh T.K. Experimental brain injury induces regionally distinct apoptosis during the acute and delayed post-traumatic period. J. Neurosci. 18:1998;5663-5672
11. Crutcher KA, Tolar M, Harmony JK, Marques MA. A new hypothesis for the role of apolipoprotein E in Alzheimer's disease pathology. In: Iqbal K, Winblad B, Nishimura T, Takeda M, Wisniewski HM, editors. Alzheimer's disease: biology, diagnosis and therapeutics; 1997. p. 545-54.
12. Dickson T.C., King C.E., McCormack G.H., Vickers J.C. Neurochemical diversity of dystrophic neurites in the early and late stages of Alzheimer's disease. Exp. Neurol. 156:1999;100-110
13. Dickson T.C., Vickers J.C. The morphological phenotype of beta-amyloid plaques and associated neuritic changes in Alzheimer's disease. Neuroscience. 105:2001;99-107
14. Donovan F.M., Pike C.J., Cotman C.W., Cunningham D.D. Thrombin induces apoptosis in cultured neurons and astrocytes via a pathway requiring tyrosine kinase and RhoA activities. J. Neurosci. 17:1997;5316-5326
15. Festoff B.W., D'Andrea M.R., Citron B.A., Salcedo R.M., Smirnova I.V., Andrade-Gordon P. Motor neuron cell death in wobbler mutant mice follows overexpression of the G-protein-coupled, protease-activated receptor for thrombin. Mol. Med. 6:2000;410-429
16. Garcia JH, Ho KL, Caccamo DV. Intracerebral hemorrhage: pathology of selected topics. In: Kase CS, Caplan LR, editors. Intracerebral hemorrhage, Boston, MA: Butterworth-Heinemann; 1994. p. 45-72.
17. Geisler N., Weber K. Self-assembly in vitro of the 68, 000 molecular weight component of the mammalian neurofilament triplet proteins into intermediate-sized filaments. J. Mol. Biol. 151:1981;565-571
18. Gill J.S., Pitts K., Rusnak F.M., Owen W.G., Windebank A.J. Thrombin induced inhibition of neurite outgrowth from dorsal root ganglion neurons. Brain Res. 797:1998;321-327
19. Gingrich M.B., Junge C.E., Lyuboslavsky P., Traynelis S.F. Potentiation of NMDA receptor function by the serine protease thrombin. J. Neurosci. 20:2000;4582-4595
20. Gould T.J., Rowe W.B., Heman K.L., Mesches M.H., Young D.A., Rose G.M., et al. Effects of hippocampal lesions on patterned motor learning in the rat. Brain Res. Bull. 58:2002;581-618
21. Grand R.J., Grabham P.W., Gallimore M.J., Gallimore P.H. Modulation of morphological differentiation of human neuroepithelial cells by serine proteases: independence from blood coagulation. EMBO J. 8:1989;2209-2215
22. Gurwicz D., Cunninham D.D. Thrombin modulates and reverses neuroblastoma neurite outgrowth. Proc. Natl. Acad. Sci. USA. 85:1988;3440-3444
23. Igarashi K., Murai H., Asaka J. Proteolytic processing of amyloid beta protein precursor (APP) by thrombin. Biochem. Biophys. Res. Commun. 185:1992;1000-1004
24. Jiang Y., Wu J., Hua Y., Keep R.F., Xiang J., Hoff J.T., et al. Thrombin-receptor activation and thrombin-induced brain tolerance. J. Cereb. Blood Flow Metab. 22:2002;404-410
25. Jordan B.D. Neurologic aspects of boxing. Arch Neurol. 44:1987;453-459
26. Lee K.R., Betz A.L., Keep R.F., Chenevert T.L., Kim S., Hoff J.T. Intracerebral infusion of thrombin as a cause of brain edema. J. Neurosurg. 83:1995;1045-1050
27. Lee K.R., Colon G.P., Betz A.L., Keep R.F., Kim S., Hoff J.T. Edema from intracerebral hemorrhage: the role of thrombin. J. Neurosurg. 84:1996;91-96
28. Lee K.R., Kawai N., Kim S., Sagher O., Hoff J.T. Mechanisms of edema formation after intracerebral hemorrhage: effects of thrombin on cerebral blood flow, blood-brain barrier permeability, and cell survival in a rat model. J. Neurosurg. 86:1997;272-278
29. Loret C., Sensenbrenner M., Labourdette G. Differential phenotypic expression induced in cultured rat astroblasts by acidic fibroblast growth factor, epidermal growth factor, and thrombin. J. Biol. Chem. 264:1989;19-27
30. Marques M.A., Tolar M., Harmony J.A.K., Crutcher K.A. A thrombin cleavage fragment of apolipoprotein E exhibits isoform-specific neurotoxicity. Neuroreport. 7:1996;2529-2532
31. Martinez I., Quirante G.L., Diaz-Cintra S., Quiroz C., Prade-Alkala R.A. Effects of lesions of hippocampal fields CA1 and CA3 on acquisition of inhibitory avoidance. Neurophysiology. 46:2002;97-103
32. Matser J.T., Kessels A.G., Jordan B.D., Lezak M.D., Troost J. Chronic traumatic brain injury in professional soccer players. Neurology. 51:1998;791-796
33. McGeer P.L., Kawamata T., Walker D., Abyama H., Toyama I., McGeer E.G. Microglia in degenerative neurological disease. Glia. 7:1993;84-92
34. Miyoshi E., Wietzikoski S., Camplessei M., Silveira R., Takahashi R.N., Da Cunha C. Impaired learning in a spatial working memory version and in a cued version of the water maze in rats with MPTP-induced mesencephalic dopaminergic lesions. Brain Res. Bull. 58:2002;41-47
35. Mortimer J.A., van Duijn C.M., Chandra V., Fratiglioni L., Graves A.B., Heyman A. Head trauma as a risk factor for Alzheimer's disease: a collaborative re-analysis of case-control studies. EURODEM Risk Factors Research Group. Int. J. Epidemiol. 20(Suppl 2):1991;S28-S35
36. Nelson R.B., Siman R. Thrombin and its inhibitors regulate morphological and biochemical differentiation of astrocytes in vitro. Dev. Brain Res. 54:1990;93-104
37. Nemetz P.N., Leibson C., Naessens J.M., Beard M., Kokmen E., Annegers J.F., et al. Traumatic brain injury and time to onset of Alzheimer's disease: a population based study. Am. J. Epidemiol. 149:1999;32-40
38. Nishino A., Suzuki M., Ohtani H., Motohashi O., Umezawa K., Nagura H., et al. Thrombin may contribute to the pathophysiology of central nervous system injury. J. Neurotrauma. 10:1993;167-179
39. Perlstein W.M., Dixit N.K., Carter C.S., Noll D.C., Cohen J.D. Prefrontal cortex dysfunction mediates deficits in working memory and prepotent responding in schizophenia. Biol. Psychiatry. 53:2003;25-38
40. Quintana J., Wong T., Ortiz-Portillo E., Kovalik E., Davidson T., Marder S.R., et al. Prefrontal-posterior parietal networks in schizophenia: primary dysfunctions and secondary compensations. Biol. Psychiatry. 53:2003;12-24
41. Reimann-Philips U., Ovase R., Weigel P.H., Grammas P. Mechanisms of cell death in primary cortical neurons and PC12 cells. J. Neurosci. Res. 64:2001;654-660
42. Roberts A.H., Brain damage in boxers. London: Pittman Medical and Scientific Publishers, 1969.
43. Sarker K.P., Abeyama K., Nishi J., Nakata M., Tokioka T., Nakajima T., et al. Inhibition of thrombin-induced neuronal cell death by recombinant thrombomodulin and E5510, a synthetic thrombin receptor signaling inhibitor. Thromb. Haemost. 82:1999;1071-1077
44. Smirnova I.V., Ma J.Y., Citron B.A., Ratzlaff K.T., Gregory E.J., Akaaboune M., et al. Neural thrombin and protease nexin I kinetics after murine peripheral nerve injury. J. Neurochem. 67:1996;2188-2199
45. 2+ homeostasis and sensitivity to glucose deprivation-induced injury. J. Neurosci. 15:1995;5840-5850
46. Striggow F., Riek M., Breder J., Henrich-Noack P., Reymann K.G., Reiser G. The protease thrombin is an endogenous mediator of hippocampal neuroprotection against ischemia at low concentrations but causes degeneration at high concentration. Proc. Natl. Acad. Sci. USA. 97:2000;2264-2269
47. Tokuda T., Ikeda S., Yanagisawa N., Ihara Y., Glenner G.G. Re-examination of ex-boxers' brains using immunohistochemistry with antibodies to amyloid beta-protein and tau protein. Acta Neuropathol. (Berl.). 82:1991;280-285
48. Turgeon V.L., Houenou L.J. Prevention of thombin-induced motoneuron degeneration with different neurotrophic factors in highly enriched cultures. J. Neurobiol. 38:1999;571-580
49. Uryu K., Laurer H., McIntosh T., Pratico D., Martinez D., Leight S., et al. Repetitive mild brain trauma accelerates Aβ deposition, lipid peroxidation, and cognitive impairment in a transgenic mouse model of Alzheimer amyloidosis. J. Neurosci. 22:2002;446-454
50. Vaughan P.L., Su J., Cotman C.W., Cunningham D. Protease nexin-1, a potent thrombin inhibitor, is reduced around cerebral blood vessels in Alzheimer's disease. Neuroreport. 5:1994;2529-2533
51. Vergnolle N., Hollenberg M.D., Wallace J.L. Pro and anti-inflammatory actions of thrombin: a distinct role for proteinase activated receptor-1 (PAR-1). Brit. J. Pharmacol. 126:1999;1262-1268
52. White R.P., Chapleau C.E., Dugdale M., Robertson J.T. Cerebral arterial contractions induced by human and bovine thrombin. Stroke. 11:1980;363-368
53. Xi G.H., Keep R.F., Hoff J.T. Erythrocytes and delayed brain edema formation following intracerebral hemorrhage in rats. J. Neurosurg. 89:1998;991-996
54. Xi G., Keep R.F., Hua Y., Xiang J., Hoff J.T. Attenuation of thrombin-induced brain edema by cerebral thrombin preconditioning. Stroke. 30:1999;1247-1255
55. Xue M., Del Bigio M.R. Acute tissue damage after injections of thrombin and plasmin into rat striatum. Stroke. 32:2001;2164-2169